Advisor Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.01M Buy
2,882
+248
+9% +$101K 0.07% 286
2022
Q1
$1.44M Buy
2,634
+378
+17% +$199K 0.09% 220
2021
Q4
$1.49M Buy
2,256
+102
+5% +$64K 0.09% 218
2021
Q3
$1.34M Sell
2,154
-132
-6% -$88.7K 0.09% 210
2021
Q2
$1.44M Sell
2,286
-19
-0.8% -$10.5K 0.09% 206
2021
Q1
$1.13M Sell
2,305
-81
-3% -$40.6K 0.08% 247
2020
Q4
$1.19M Buy
2,386
+43
+2% +$19.2K 0.09% 207
2020
Q3
$921K Sell
2,343
-69
-3% -$25.5K 0.08% 229
2020
Q2
$796K Sell
2,412
-32
-1% -$9.27K 0.07% 239
2020
Q1
$592K Buy
2,444
+50
+2% +$13K 0.07% 253
2019
Q4
$691K Buy
2,394
+15
+0.6% +$3.95K 0.07% 274
2019
Q3
$647K Buy
2,379
+158
+7% +$44K 0.08% 268
2019
Q2
$612K Buy
2,221
+62
+3% +$15.3K 0.07% 267
2019
Q1
$483K Sell
2,159
-248
-10% -$51.2K 0.06% 307
2018
Q4
$448K Sell
2,407
-92
-4% -$18.9K 0.07% 298
2018
Q3
$624K Sell
2,499
-75
-3% -$18.2K 0.08% 255
2018
Q2
$561K Buy
2,574
+85
+3% +$17.5K 0.09% 253
2018
Q1
$476K Sell
2,489
-336
-12% -$62K 0.09% 277
2017
Q4
$510K Buy
2,825
+45
+2% +$7.08K 0.09% 261
2017
Q3
$432K Sell
2,780
-87
-3% -$13.8K 0.08% 266
2017
Q2
$463K Buy
2,867
+157
+6% +$25.5K 0.11% 231
2017
Q1
$419K Buy
2,710
+578
+27% +$79.7K 0.11% 234
2016
Q4
$250K Buy
2,132
+209
+11% +$23.9K 0.08% 324
2016
Q3
$217K Buy
+1,923
New +$203K 0.07% 340

Other funds holding IDXX

Advisor Partners's IDXX Position: Q2 2022 in Review

Advisor Partners increased its Idexx Laboratories (IDXX) stake by 9.4% in Q2 2022, buying an estimated $101K and bringing the position to 2,882 shares worth $1.01M. The position accounts for 0.07% of the portfolio, ranked #286.

Advisor Partners first reported a position in IDXX in Q3 2016 and has held it in 24 quarters since. The position peaked at $1.49M in Q4 2021. 957 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

  • Advisor Partners held 2,882 shares of Idexx Laboratories worth $1.01M as of Q2 2022.
  • Advisor Partners bought 248 Idexx Laboratories shares in Q2 2022, an estimated $101K.
  • Idexx Laboratories made up 0.07% of Advisor Partners's portfolio in Q2 2022, its #286 holding.
  • Advisor Partners first reported a position in Idexx Laboratories in Q3 2016 and has held it in 24 quarters since.
  • Advisor Partners's Idexx Laboratories position peaked at $1.49M in Q4 2021.
  • 957 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.